Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Saved in:
Bibliographic Details
Title: Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Authors: Moolenaar LR; Department of Surgery, Amsterdam University Medical Center, Amsterdam, Netherlands; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Ali M; Department of Surgery, Amsterdam University Medical Center, Amsterdam, Netherlands; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Aufenacker TJ; Department of Surgery, Rijnstate Hospital, Arnhem, Netherlands., Beets GL; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands., Bosker RJI; Department of Surgery, Deventer Hospital, Deventer, Netherlands., Buffart TE; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, Netherlands., Burger JW; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Dekker E; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, Netherlands., Denost Q; Department of Colorectal Surgery, Bordeaux Colorectal Institute, Clinique Tivoli-Ducos, Bordeaux, France., Doornebosch PG; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, Netherlands., Duijvendijk PV; Department of Surgery, Gelre Hospital, Apeldoorn, Netherlands., Fabry HFJ; Department of Surgery, Bravis Hospital, Roosendaal, Netherlands., Geijsen ED; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, Netherlands., Gerhards MF; Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., van Grevenstein WMU; Department of Surgery, University Medical Center Utrecht, Utrecht, Netherlands., Grotenhuis BA; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands., Hoff C; Department of Surgery, Medisch Centrum Leeuwarden, Leeuwarden, Netherlands., Leijtens JWA; Department of Surgery, Laurentius Hospital, Roermond, Netherlands., Peeters KCMJ; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands., Pronk A; Department of Surgery, Diakonessenhuis, Utrecht, Netherlands., van der Schelling GP; Department of Surgery, Amphia, Breda, Netherlands., Sietses C; Department of Surgery, Gelderse Vallei Hospital, Ede, Netherlands., Smits AB; Department of Surgery, St Antonius Hospital, Nieuwegein, Netherlands., Toorenvliet BR; Department of Surgery, Ikazia Hospital, Rotterdam, Netherlands., van de Ven AWH; Department of Surgery, Flevo Hospital, Almere, Netherlands., Verdaasdonk EGG; Department of Surgery, Jeroen Bosch Hospital, Den Bosch, Netherlands., Vuylsteke RJCLM; Department of Surgery, Spaarne Gasthuis, Haarlem, Netherlands., van Westreenen HL; Department of Surgery, Isala Hospital, Zwolle, Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Center, Nijmegen, Netherlands., Zimmerman DDE; Department of Surgery, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands., Lange MM; Department of Pathology, Amsterdam University Medical Center, Amsterdam, Netherlands., van Grieken NCT; Department of Pathology, Amsterdam University Medical Center, Amsterdam, Netherlands., Bastiaansen BAJ; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, Netherlands., Hompes R; Department of Surgery, Amsterdam University Medical Center, Amsterdam, Netherlands; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Marijnen CA; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands., Dijkgraaf MGW; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Amsterdam, Netherlands., Moons LMG; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands., Tanis PJ; Department of Surgery, Erasmus Medical Center, Rotterdam, Netherlands., Cunningham C; Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Tuynman JB; Treatment and Quality of Life and Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands. Electronic address: j.tuynman@amsterdamumc.nl.
Corporate Authors: TESAR Study Group
Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2026 Jul; Vol. 11 (7), pp. 557-569. Date of Electronic Publication: 2026 May 27.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase III; Equivalence Trial; Randomized Controlled Trial; Comparative Study
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2468-1253
DOI:10.1016/S2468-1253(26)00109-3